|
What is the optimal strategy for identifying contacts of infected individuals? |
To which extent has the virus mutated during the global transmission? |
What is the proportion of super-spreaders among the whole cohort of patients with COVID-19? |
|
Is there evidence of pre-symptomatic viral shedding? |
What is the time point of viral shedding and what is the association with disease progression? |
Are patients with a relapse of positive viral RNA findings contagious when discharged home? |
What is the natural course of severe and non-severe cases? |
|
What is the characteristic and mechanism of mucus hypersecretion in small airways? |
How does SARS-CoV-2 result in lymphopenia and inflammatory cytokine storm? |
What is the most valuable biomarker for predicting the clinical outcomes of COVID-19? |
Could artificial intelligence aid in the diagnosis and phenotyping COVID-19? |
|
Will inhibitors of viral replication be effective in the clearance of COVID-19? |
What are the most cost-effective managements for COVID-19? |
When should be the optimal timing and duration for intubation? |
Which medication(s) may be useful to suppress the inflammatory cytokine storm? |